| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |